Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alginate and Chitosan-Based Hydrogels for the Treatment of Radiation Dermatitis.

International wound journal·2026
Same author

Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery.

Pharmaceutics·2025
Same author

Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations.

Pharmaceutics·2025
Same author

PEGylated Nanoliposomes Encapsulated with Anticancer Drugs for Breast and Prostate Cancer Therapy: An Update.

Pharmaceutics·2025
Same author

Hybrid Molecules Containing Methotrexate, Vitamin D, and Platinum Derivatives: Synthesis, Characterization, In Vitro Cytotoxicity, In Silico ADME Docking, Molecular Docking and Dynamics.

Chemistry & biodiversity·2024
Same author

Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics.

Molecules (Basel, Switzerland)·2024

Related Experiment Video

Updated: Jan 6, 2026

Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
07:07

Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology

Published on: March 12, 2015

10.0K

Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.

Sijongesonke Peter1, Blessing Atim Aderibigbe2

  • 1Department of Chemistry, University of Fort Hare, Alice campus, Eastern Cape 5700, South Africa. 201414787@ufh.ac.za.

Molecules (Basel, Switzerland)
|October 9, 2019
PubMed
Summary

Ferrocene compounds show promise for treating malaria and cancer, offering enhanced biological activity. Hybridizing ferrocene with other molecules creates potent anticancer and antimalarial agents, addressing drug resistance and toxicity.

Keywords:
cancerferrocene compoundsferroquinemalariaorganometallics

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.7K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.9K

Related Experiment Videos

Last Updated: Jan 6, 2026

Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology
07:07

Synthetic Methodology for Asymmetric Ferrocene Derived Bio-conjugate Systems via Solid Phase Resin-based Methodology

Published on: March 12, 2015

10.0K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.7K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.9K

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Pharmacology

Background:

  • Malaria and cancer are chronic diseases with challenges in drug toxicity and resistance.
  • Ferrocene, an organometallic compound, can be hybridized to enhance biological activity.
  • Existing drugs like ferroquine demonstrate the potential of ferrocene-based antimalarials.

Purpose of the Study:

  • To review ferrocene-containing compounds with anticancer or antimalarial activity.
  • To highlight the role of ferrocene hybridization in developing novel therapeutic agents.
  • To explore the potential of ferrocene derivatives in combating drug resistance.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of studies reporting ferrocene compounds with biological activity.
  • Focus on compounds exhibiting antimalarial or anticancer properties.

Main Results:

  • Ferrocene hybridization yields compounds with significant anticancer and antimalarial potential.
  • Ferrocene derivatives have shown efficacy against drug-resistant malaria strains.
  • Numerous studies confirm the potent activity of hybridized ferrocene compounds.

Conclusions:

  • Ferrocene-based compounds represent a promising class of therapeutic agents for malaria and cancer.
  • Hybridization strategies involving ferrocene can overcome existing drug limitations.
  • Further research into ferrocene derivatives is warranted for drug development.